ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

367
Analysis
Health Care • China
Shanghai Henlius Biotech is a global, innovation-driven biopharmaceutical company focused on delivering high-quality, affordable biologic therapies for oncology, autoimmune diseases, and ophthalmic diseases. The company is engaged in biopharmaceutical research and development, manufacturing, and commercialization, offering products such as the biosimilars HANLIKANG (rituximab), HANQUYOU (trastuzumab), HANDAYUAN (adalimumab), and HANBEITAI (bevacizumab), as well as the innovative biologic HANSIZHUANG (serplulimab). Headquartered in Shanghai, China, the company was founded in 2010.
more
bullish•Quantitative Analysis
•13 Sep 2026 10:05

HK Connect Flows Weekly (Sep 11th): Smic, Bidu, Hua Hong Semi, Zj Innolight, Xiaomi, Tencent

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Smic, Bidu, Hua Hong Semi, Zj Innolight, Xiaomi, Tencent,...

Logo
102 Views
Share
bullish•Sigenergy Technology
•06 Sep 2026 11:20

HSCI / HK Connect Sep 2026 Implementation: Pre-Implementation Update

HK Connect enters implementation on 7 Sep 2026. We update stock performance since the HSCI announcement and discuss the implementation trade.

Logo
139 Views
Share
bullish•Cross Asset Strategy
•29 Jun 2024 08:10

The Heat Is On: News Flow and Sentiment in HONG KONG

China had positive flows into equity ETF's for June and mainland investors continued to direct money to Hong Kong stocks through the Stock Connect...

Logo
749 Views
Share
bearish•Cross Asset Strategy
•27 Jun 2024 12:52•Syndicated

CX Daily: Consumers, Entrepreneurs Give Banks’ Retail Lending a Much-Needed Boost

Retail lending / In Depth: Consumers, entrepreneurs give banks’ retail lending a much-needed boost Despite market saturation stunting the credit...

Logo
270 Views
Share
bullish•Sigenergy Technology
•23 Aug 2026 11:18

HSCI / HK Connect Sep 2026 Rebalance: Post-Announcement Positioning

HSIL announced the September review result on 21 Aug 2026 after market close. We forecast 53 southbound Connect ADDs and 15 DELETEs. We review the...

Logo
129 Views
Share
x